Modulation of immunodominance in HLA class I associated uveitides
HLA I 类相关葡萄膜的免疫优势调节
基本信息
- 批准号:10557821
- 负责人:
- 金额:$ 45.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAffectAllelesAnterior uveitisAutoimmunityAutologousBehcet&aposs eye diseaseBindingBlindnessCD8-Positive T-LymphocytesCD8B1 geneCRISPR/Cas technologyCell surfaceCellsClonal ExpansionCloningDataDiseaseEndoplasmic ReticulumEpitopesEtiologyEyeGenerationsGenetic EpistasisGenetic PolymorphismGenotypeGoalsHLA-B AntigensHLA-B27 AntigenHLA-Bw51HaplotypesHealthHigh PrevalenceHumanImmune System DiseasesImmune responseImmune systemImmunityImmunogeneticsInflammationInsertional MutagenesisKnowledgeLigandsLiteratureMediatingMolecular TargetOutcomePathogenesisPathogenicityPathologicPatientsPeptidesPersonsPrediction of Response to TherapyPsoriasisPsoriatic ArthritisPublishingQuality of lifeResearchRiskSeriesT cell responseUveitisVariantViral Antigensdisorder controleconomic costeconomic impacteffector T cellenzyme activityexperimental studygene therapygenetic testinggenome editinghigh riskimmunogenicimmunogenicitypatient subsetspharmacologicpreventtargeted treatmenttherapeutic targettherapy design
项目摘要
ABSTRACT/PROJECT SUMMARY
Variants at ERAP1 modulate the risk for several forms of non-infectious uveitis in the presence of disease-
associated HLA class I, strongly suggesting a so far unproven change in immunodominance with impact on
disease causation and protection.
The overall objective of this application is to determine through which mechanism ERAP1 allotypes cause and
protect from HLA I-associated uveitis. Our long-term goal is to understand and therapeutically target HLA class
I associated autoimmunity in uveitis.
Our central hypothesis is that allotypic ERAP1 alters the HLA I-bound peptidome to include epitopes that
are immunogenic when presented by disease-relevant HLA I, which induces or controls disease through a
change in immunodominance. The rationale for this study is that mechanistic understanding of ERAP1-mediated
pathogenesis in HLA I immunity will enable targeted therapy design aimed at specific ERAP1-HLA I-uveitis
subsets.
Based on these considerations we will implement two specific aims. In Aim 1 we will determine through
which mechanism the allotype ERAP1 Hap10 initiates immune dysfunction in HLA-B*51+ Behçet’s uveitis (BU)
but protects from HLA-B*27+ acute anterior uveitis (AAU) via a series of CRISPR/Cas9 genome editing
experiments. These experiments will allow us to define its functional contribution to the HLA I restricted
peptidomes relevant to each of these disorders and their effect on the generation of immunogenic or tolerogenic
immune responses. In Aim 2 we will establish how HLA I restricted pathogenic epitopes depend on allotype-
specific ERAP1 function through the exploitation of clonally expanded CD8 T cells from active BU and AAU
patients for cellular cloning, genome-editing and functional assessment of immunogenicity.
We expect the following outcomes 1) knowledge of the immunogenic and tolerogenic effects mediated
by allotypic ERAP1 in two highly disease-relevant HLA restriction contexts: HLA-B27 and B51, 2) identity of
epitopes that induce or prevent immunogenicity in these contexts, 3) proof of principle that allotypic ERAP1
regulates autoimmunity and that manipulation of its activity modulates pathogenicity providing irrefutable
rationale for targeting ERAP1 enzyme activity pharmacologically, or through gene therapy. This will have a
positive impact on the field through the identification of molecular targets allowing the design of therapy for
patient groups defined by genotypes, and through mechanistic understanding extending beyond the scope of
BU and AAU to additional MHC-I-opathies with immense impact on human health, such as IBD, psoriasis, and
psoriatic arthritis.
摘要/项目摘要
ERAP1 的变体在存在疾病的情况下调节多种形式的非感染性葡萄膜炎的风险 -
相关的 HLA I 类,强烈表明迄今为止未经证实的免疫优势变化对
疾病的因果关系和保护。
本申请的总体目标是确定 ERAP1 同种异型通过哪种机制引起和
预防 HLA I 相关葡萄膜炎。我们的长期目标是了解 HLA 类别并进行治疗
我与葡萄膜炎的自身免疫有关。
我们的中心假设是,同种异型 ERAP1 改变了 HLA I 结合肽组,以包含以下表位:
当由疾病相关的 HLA I 呈现时具有免疫原性,HLA I 通过以下方式诱导或控制疾病:
免疫优势的改变。这项研究的基本原理是对 ERAP1 介导的机制的理解
HLA I 免疫的发病机制将使针对特定 ERAP1-HLA I 葡萄膜炎的靶向治疗设计成为可能
子集。
基于这些考虑,我们将实现两个具体目标。在目标 1 中,我们将通过以下方式确定
同种异型 ERAP1 Hap10 启动 HLA-B*51+ Behçet 葡萄膜炎 (BU) 免疫功能障碍的机制
但通过一系列 CRISPR/Cas9 基因组编辑可预防 HLA-B*27+ 急性前葡萄膜炎 (AAU)
实验。这些实验将使我们能够定义其对 HLA I 限制性的功能贡献
与这些疾病相关的肽组及其对免疫原性或耐受性产生的影响
免疫反应。在目标 2 中,我们将确定 HLA I 限制性致病表位如何依赖于同种异型-
通过利用来自活性 BU 和 AAU 的克隆扩增 CD8 T 细胞实现特定 ERAP1 功能
患者进行细胞克隆、基因组编辑和免疫原性功能评估。
我们期望获得以下结果 1) 了解介导的免疫原性和耐受性效应
通过同种异型 ERAP1 在两个与疾病高度相关的 HLA 限制环境中进行:HLA-B27 和 B51,2) 的身份
在这些情况下诱导或防止免疫原性的表位,3)同种异型 ERAP1 的原理证明
调节自身免疫并且操纵其活性调节致病性提供了无可辩驳的证据
通过药理学或基因疗法靶向 ERAP1 酶活性的基本原理。这将有一个
通过识别分子靶标,设计治疗方案,对该领域产生积极影响
由基因型定义的患者群体,并通过超越范围的机制理解
BU 和 AAU 涉及对人类健康具有巨大影响的其他 MHC-I 疾病,例如 IBD、牛皮癣和
银屑病关节炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johannes Nowatzky其他文献
Johannes Nowatzky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Johannes Nowatzky', 18)}}的其他基金
Modulation of immunodominance in HLA class I associated uveitides
HLA I 类相关葡萄膜的免疫优势调节
- 批准号:
10345839 - 财政年份:2022
- 资助金额:
$ 45.77万 - 项目类别:
Unraveling the role of HLA-B51/ERAP1 in Behcet's eye disease
揭示 HLA-B51/ERAP1 在白塞氏眼病中的作用
- 批准号:
10534165 - 财政年份:2021
- 资助金额:
$ 45.77万 - 项目类别:
Unraveling the role of HLA-B51/ERAP1 in Behcet's eye disease
揭示 HLA-B51/ERAP1 在白塞氏眼病中的作用
- 批准号:
10328964 - 财政年份:2021
- 资助金额:
$ 45.77万 - 项目类别:
Harnessing monoclonal Treg for the treatment of autoimmune uveitis
利用单克隆 Treg 治疗自身免疫性葡萄膜炎
- 批准号:
8869794 - 财政年份:2015
- 资助金额:
$ 45.77万 - 项目类别:
Harnessing monoclonal Treg for the treatment of autoimmune uveitis
利用单克隆 Treg 治疗自身免疫性葡萄膜炎
- 批准号:
9045643 - 财政年份:2015
- 资助金额:
$ 45.77万 - 项目类别:
Harnessing monoclonal Treg for the treatment of autoimmune uveitis
利用单克隆 Treg 治疗自身免疫性葡萄膜炎
- 批准号:
9265471 - 财政年份:2015
- 资助金额:
$ 45.77万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 45.77万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 45.77万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 45.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 45.77万 - 项目类别:
Studentship














{{item.name}}会员




